FDA Adverse Event Malfunction Summary report: N

2520274-2013-05321

MDR report key: 3324890 · Received September 4, 2013

Report

Report Number
2520274-2013-05321
Event Type
Malfunction
Date Received
September 4, 2013
Report Date
August 9, 2013
Manufacturer
SYNTHES USA
Product Code
HSB
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS USED FOR TREATMENT, NOT DIAGNOSIS. THIS REPORT IS FOR 2 UNKNOWN PFNA NAILS. DEVICE IS NOT DISTRIBUTED IN THE UNITED STATES, BUT IS SIMILAR TO A DEVICE MARKETED IN THE USA. INVESTIGATION COULD NOT BE COMPLETED, NO CONCLUSION COULD BE DRAWN AS NO DEVICE WAS RETURNED AND NO LOT NUMBER WAS PROVIDED. MANUFACTURING RECORDS COULD NOT BE REVIEWED WITHOUT A LOT NUMBER. PLACEHOLDER.

Description of Event or Problem · 1

JOURNAL ARTICLE RECEIVED: THE NEW PROXIMAL FEMORAL NAIL ANTIROTATION (PFNA) IN DAILY PRACTICE: RESULTS OF A MULTICENTRE CLINICAL STUDY, INJURY, 2008: 39: 932-939. AUTHORS: R. KI. J. SIMMERMACHER, J. LJUNGQVIST, H. BAIL, T. HOCKERTZ, A. J. H. VOCHTELOO, U. OCHS, CHR.V.D. WERKEN. STUDY WAS COMPRISED OF 313 PATIENTS WITH 315 UNSTABLE TROCHANTERIC FRACTURES ALL TREATED WITH PFNA. THE MEAN AGE WAS 80.6 YEARS, 77 PERCENT WERE FEMALE. 299 PATIENTS HAD A SINGLE ISOLATED FRACTURE, 53 PERCENT WERE ON THE LEFT AND ALL WERE OF TRAUMATIC ORIGIN. EIGHTY-TWO PERCENT WERE 31.A.2 FRACTURES AND 18 PERCENT WERE 31.A.3 FRACTURES, ALL WERE CLOSED. NINETY-EIGHT PERCENT OF THE FRACTURES WERE UNITED, THE MAJORITY (92 PERCENT) WERE WITHIN 6 MONTHS. THERE WAS A TOTAL OF 165 ADVERSE EVENTS. ONE HUNDRED SEVENTEEN WERE NOT IMPLANT RELATED. FORTY-SIX EVENTS WERE OPERATION OR IMPLANT RELATED RESULTING IN 28 UNPLANNED REOPERATIONS. THIS REPORT IS FOR TWO INSTANCES OF BLADE LOOSENING, ONE WITHIN 6 MONTHS. OUTCOME OF THESE TWO INCIDENTS IS UNKNOWN. THIS REPORT IS 1 OF 2 FOR COMPLAINT (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
439926 HSB SYNTHES USA

Patients

Seq Age Sex Outcome Treatment
1